Literature DB >> 33691086

Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter.

Bart De Geest1, Mudit Mishra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33691086      PMCID： PMC8058485          DOI： 10.1016/j.ymthe.2021.03.001

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage.

Authors:  Judith Haendeler; Stefan Dröse; Nicole Büchner; Sascha Jakob; Joachim Altschmied; Christine Goy; Ioakim Spyridopoulos; Andreas M Zeiher; Ulrich Brandt; Stefanie Dimmeler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-05       Impact factor: 8.311

2.  Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-induced cardiotoxicity.

Authors:  D Cova; L De Angelis; E Monti; F Piccinini
Journal:  Free Radic Res Commun       Date:  1992

3.  Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.

Authors:  Kendall B Wallace; Vilma A Sardão; Paulo J Oliveira
Journal:  Circ Res       Date:  2020-03-26       Impact factor: 17.367

4.  Telomerase therapy attenuates cardiotoxic effects of doxorubicin.

Authors:  Shambhabi Chatterjee; Teresa Hofer; Alessia Costa; Dongchao Lu; Sandor Batkai; Shashi Kumar Gupta; Emiliano Bolesani; Robert Zweigerdt; Diego Megias; Katrin Streckfuss-Bömeke; Christina Brandenberger; Thomas Thum; Christian Bär
Journal:  Mol Ther       Date:  2021-01-01       Impact factor: 11.454

Review 5.  Mitochondria, Telomeres and Telomerase Subunits.

Authors:  Qian Zheng; Jinliang Huang; Geng Wang
Journal:  Front Cell Dev Biol       Date:  2019-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.